SG11202011229RA - Methods and compositions for inhibiting a noxious insult - Google Patents
Methods and compositions for inhibiting a noxious insultInfo
- Publication number
- SG11202011229RA SG11202011229RA SG11202011229RA SG11202011229RA SG11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA SG 11202011229R A SG11202011229R A SG 11202011229RA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibiting
- compositions
- methods
- noxious insult
- insult
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018901826A AU2018901826A0 (en) | 2018-05-25 | Methods and compositions for inhibiting a noxious insult | |
PCT/AU2018/051226 WO2019222788A1 (en) | 2018-05-25 | 2018-11-16 | Methods and compositions for inhibiting a noxious insult |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202011229RA true SG11202011229RA (en) | 2020-12-30 |
Family
ID=65365420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202011229RA SG11202011229RA (en) | 2018-05-25 | 2018-11-16 | Methods and compositions for inhibiting a noxious insult |
Country Status (9)
Country | Link |
---|---|
US (2) | US20210212932A1 (en) |
EP (1) | EP3801567A4 (en) |
JP (1) | JP7231717B2 (en) |
KR (1) | KR20210096558A (en) |
CN (1) | CN112912086A (en) |
AU (1) | AU2018260927B1 (en) |
CA (1) | CA3101482A1 (en) |
SG (1) | SG11202011229RA (en) |
WO (1) | WO2019222788A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05213764A (en) * | 1992-02-03 | 1993-08-24 | Terumo Corp | Oxygen radical scavenger |
US5955111A (en) * | 1996-10-08 | 1999-09-21 | Hartford Hospital | Methods and compositions for inducing production of stress proteins |
CA2346334A1 (en) * | 1998-10-14 | 2000-04-20 | Shionogi & Co., Ltd. | Composition for treating or preventing ischemia reperfusion injury |
JP2003503346A (en) * | 1999-06-23 | 2003-01-28 | ジンク セラピューテイクス カナダ インコーポレイテッド | Zinc ionophore as an anti-apoptotic agent |
EP2146711A4 (en) * | 2007-04-12 | 2011-10-26 | Univ Minnesota | Ischemia/reperfusion protection compositions and methods of using |
-
2018
- 2018-11-09 AU AU2018260927A patent/AU2018260927B1/en active Active
- 2018-11-16 KR KR1020207036608A patent/KR20210096558A/en not_active Application Discontinuation
- 2018-11-16 JP JP2021515252A patent/JP7231717B2/en active Active
- 2018-11-16 US US17/058,441 patent/US20210212932A1/en not_active Abandoned
- 2018-11-16 CN CN201880095964.5A patent/CN112912086A/en active Pending
- 2018-11-16 WO PCT/AU2018/051226 patent/WO2019222788A1/en unknown
- 2018-11-16 SG SG11202011229RA patent/SG11202011229RA/en unknown
- 2018-11-16 EP EP18919676.9A patent/EP3801567A4/en active Pending
- 2018-11-16 CA CA3101482A patent/CA3101482A1/en active Pending
-
2024
- 2024-03-26 US US18/616,477 patent/US20240238195A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021526550A (en) | 2021-10-07 |
EP3801567A1 (en) | 2021-04-14 |
KR20210096558A (en) | 2021-08-05 |
CA3101482A1 (en) | 2019-11-28 |
CN112912086A (en) | 2021-06-04 |
US20210212932A1 (en) | 2021-07-15 |
WO2019222788A1 (en) | 2019-11-28 |
US20240238195A1 (en) | 2024-07-18 |
AU2018260927B1 (en) | 2019-02-21 |
EP3801567A4 (en) | 2022-04-20 |
JP7231717B2 (en) | 2023-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277079A (en) | Cartyrin compositions and methods for use | |
SG11202103666PA (en) | Methods and Compositions for Editing RNAs | |
IL280134A (en) | Anti-cd112r compositions and methods | |
IL280508A (en) | Geopolymer compositions and methods for making same | |
PT3626699T (en) | Ssao inhibitor | |
EP3426732A4 (en) | Polymeric agents and compositions for inhibiting corrosion | |
HK1251610A1 (en) | Compositions and methods for inhibiting factor d | |
IL268684A (en) | Compositions and methods for immunooncology | |
IL280123A (en) | Compounds and methods for reducing atxn2 expression | |
IL275539A (en) | Compositions and methods for inhibiting aldh2 expression | |
IL288024A (en) | Methods and compositions for preventing type | |
IL279255A (en) | Compositions and methods for evaluating genomic alterations | |
EP3737372C0 (en) | Methods and compositions utilizing rrx-001 for radioprotection | |
IL274524A (en) | Compositions and methods for aquaculturing | |
PL3567061T3 (en) | Polypropylene pipe composition | |
IL291202A (en) | Compositions and methods for characterizing a microbiome | |
GB201818084D0 (en) | Compositions and methods | |
IL280330A (en) | Compositions and related methods for agriculture | |
IL290325A (en) | Biopharmacuetical compositions and related methods | |
IL284327A (en) | Compositions and methods for inhibiting hmgb1 expression | |
GB201819987D0 (en) | Methods and compositions | |
GB201817444D0 (en) | Methods and compositions | |
GB201819045D0 (en) | Csf1r binding agents | |
SG11202011229RA (en) | Methods and compositions for inhibiting a noxious insult | |
IL287316A (en) | Compounds and compositions |